Difficulty: Medium
Average Score: 76%
Practice
Bronchodilator response to an inhaled B-agonist (e.g., albuterol) is greater in asthmatic patients than in non-asthmatic persons. The rate of improvement in FEV1 consistent with asthma is
Correct answer
D
Rationale
In the context of asthma, bronchodilator response to an inhaled B-agonist like albuterol is a key diagnostic tool. The correct answer, option D (>15%), is indicative of a significant improvement in forced expiratory volume in 1 second (FEV1) after bronchodilator administration, which is consistent with asthma. Asthmatic patients typically show a greater response to bronchodilators due to the bronchoconstriction present in their airways.
Options A, B, and C are incorrect because they suggest lower rates of improvement in FEV1. A response of less than 15% would not be considered significant in the context of asthma diagnosis. Understanding the specific thresholds for bronchodilator response is crucial for healthcare providers in diagnosing and managing asthma in pediatric patients.
Educationally, this question highlights the importance of recognizing the characteristic bronchodilator response seen in asthmatic patients. It reinforces the need for healthcare professionals to interpret pulmonary function test results accurately to guide appropriate treatment decisions for pediatric patients with asthma. By understanding the significance of bronchodilator response rates, nurses and other healthcare providers can better assess, manage, and educate pediatric patients and their families about asthma management strategies.
Options A, B, and C are incorrect because they suggest lower rates of improvement in FEV1. A response of less than 15% would not be considered significant in the context of asthma diagnosis. Understanding the specific thresholds for bronchodilator response is crucial for healthcare providers in diagnosing and managing asthma in pediatric patients.
Educationally, this question highlights the importance of recognizing the characteristic bronchodilator response seen in asthmatic patients. It reinforces the need for healthcare professionals to interpret pulmonary function test results accurately to guide appropriate treatment decisions for pediatric patients with asthma. By understanding the significance of bronchodilator response rates, nurses and other healthcare providers can better assess, manage, and educate pediatric patients and their families about asthma management strategies.